Integration of PhaseV's Trial Optimizer with Bioforum's Biometric CRO Services Creates an End-to-End Solution for Smarter, Faster, and More Efficient Clinical Trials
BOSTON, Sept. 9, 2025 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, today announced a strategic partnership with Bioforum, a leading Contract Research Organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry. The collaboration will integrate PhaseV's Trial Optimizer platform module directly into Bioforum's service offerings, creating a single, AI-powered pathway from protocol planning to study execution. The solution enables research sponsors to design, simulate, and optimize complex adaptive and Bayesian trials. It will help accelerate study timelines, reduce costs, and improve the likelihood of success, while ensuring scientific rigor and regulatory compliance.
PhaseV's Trial Optimizer applies AI/ML to simulate and compare millions of trial configurations in minutes, allowing sponsors to identify the most efficient design before the first patient is enrolled in a study. Integrated into Bioforum's biometric services, the platform removes costly handoffs between design and delivery teams, reduces the risk of protocol amendments, and accelerates decision-making across therapeutic areas.
"Sponsors often face costly delays, inefficiencies, and data gaps when trial design and execution are managed separately," said Amir Malka, CEO and Co-founder of Bioforum. "By embedding PhaseV's optimization engine into Bioforum's workflow, we're tackling a challenge that has long hindered progress in clinical research. This collaboration enables a direct route to smarter, more agile trials that start strong and stay on track – accelerating timelines, reducing costs, and ultimately helping get treatments to patients faster."
With deep biometrics expertise and a commitment to data quality, Bioforum provides data management, biostatistics, statistical programming, and medical writing services to pharmaceutical, biotech, and medical device companies worldwide. Integrating Trial Optimizer into these offerings expands Bioforum's ability to support efficient, high-quality studies across a range of therapeutic areas.
"As clinical trials become increasingly complex, sponsors are demanding smarter and faster ways to design studies that maximize the probability of success," said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. "This partnership gives trial sponsors the ability to simulate millions of scenarios and move seamlessly from design to execution without losing time."
The PhaseV platform enables faster iteration, improved statistical confidence, and reduced operational friction, so that sponsors can execute optimized clinical trials without incurring additional design-to-delivery transition fees. In a recent simulation for an obesity study, the platform identified a design that reduced sample size by ~20% while preserving statistical power, translating into tens of millions of dollars in cost savings and faster trial completion.
About PhaseV
PhaseV is developing advanced AI/ML solutions to optimize clinical development. Biopharma sponsors and CROs are leveraging PhaseV's platform to rapidly design and execute adaptive, Bayesian and fixed clinical trials, analyze data to uncover heterogeneous treatment effects, stratify patients, and inform future R&D and portfolio decisions. PhaseV's platform has reduced trial costs by 50%, decreased enrollment size and trial duration by 40%, and increased the probability of trial success by over 30%. To date, the company has delivered results for more than 30 leading pharma/biotech sponsors and CROs spanning multiple therapeutic areas, including neurology, oncology, immunology, GI, rare diseases, and others.
Learn more at www.PhaseVTrials.com and follow us on LinkedIn.
About Bioforum
Bioforum The Data Masters is a leading global clinical research organization (CRO) that specializes in biometric services and solutions for the pharmaceutical, biotech and medical device industries. With a team of experienced professionals and state-of-the-art technology, Bioforum provides a range of services including data management, biostatistics, statistical programming and medical writing to help companies bring new drugs and therapies to market faster. To learn more about us and our services, visit www.bioforumgroup.com or find us on LinkedIn at https://il.linkedin.com/company/bioforum-ltd.
Photo - https://mma.prnewswire.com/media/2768523/PhaseV_Bioforum.jpg
Logo - https://mma.prnewswire.com/media/2267452/PhaseV_logo.jpg
Media Contacts:
Ellie Hanson
FINN Partners for PhaseV
[email protected]
Tali Rahinstein for Bioforum
[email protected]
SOURCE PhaseV; Bioforum
Share this article